Other targets that have been associated with prostate cancer metastasis (or progression) include BIRC5/survivin [83], EZH2 [84], TOP2A [85,86], HMMR [87], LPL [88], and SSTR1 [89]. Here, EZH2 is linked to prostate cancer.